Ages2Come
Menu
View all results →
Categories
⚡ Breaking
Japanese green tea giant Ito En surges 8%, defying a broad market sell-off Australia posts second-quarter growth of 2.1%, beating expectations Fake 10 Downing Street listing exposes 'unfit' Booking.com, says consumer group Massachusetts’ 80-year-old senator sees off primary challenge over his age Pentagon chaos deepens after Driscoll quits in clash with Hegseth Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate Apple Maps changes Lake Ontario to Lake America after Trump order Larry Page’s flying car company Pivotal loses its CEO Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics SEC proposes transfer agent rule, sets event to figure out round-the-clock U.S. trading Japanese green tea giant Ito En surges 8%, defying a broad market sell-off Australia posts second-quarter growth of 2.1%, beating expectations Fake 10 Downing Street listing exposes 'unfit' Booking.com, says consumer group Massachusetts’ 80-year-old senator sees off primary challenge over his age Pentagon chaos deepens after Driscoll quits in clash with Hegseth Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate Apple Maps changes Lake Ontario to Lake America after Trump order Larry Page’s flying car company Pivotal loses its CEO Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics SEC proposes transfer agent rule, sets event to figure out round-the-clock U.S. trading
Business / General

GSK Agrees to Buy Nuvalent for $10.6 Billion

Source: bloombergMarkets June 9, 2026 · 00:14
GSK agreed to buy Nuvalent in a deal valued at $10.6 billion, adding a biotech firm that’s developing treatments for lung cancer as the British pharmaceutical company seeks to rebuild its oncology franchise. Sam Fazeli of Bloomberg Intelligence has more. (Source: Bloomberg)
Read original article ← Back to General

The original article opens on the publisher's website.

More from General

View topic →
Countries mentioned
United Kingdom